United States · FDA National Drug Code directory
ISOSORBIDE MONONITRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-540_55810c9d-1140-40b8-a297-210a84afc05a
- Product NDC
- 59651-540
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- ISOSORBIDE MONONITRATE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221107
- Source listing expiry
- 20261231
Source-listed ingredients
- ISOSORBIDE MONONITRATE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-540-01) · 59651-540-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-540-05) · 59651-540-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →